Pharma company Eli Lilly has awarded U.S. media AOR duties to Publicis Groupe’s Zenith after a review that included incumbent OMD, WPP and Dentsu. OMD held the account for two decades.
Lilly spends an estimated $550 million on measured media annually according to agency research firm COMvergence. Total ad expenditures last year were $1.1 billion, or less than 5% of annual revenue, Lilly stated in its 2020 annual report. The company said its primary ad channels are television, radio, print, and online.
Lilly markets dozens of drugs in the U.S. including Prozac, Dolophine, Cymbalta , and Zyprexa.
The award continues a win streak for Publicis Groupe. Other recent wins include Meta, Walmart and Stellantis.
Lilly issued a statement: “As part of our Marketing transformation goals, Lilly aims to create remarkable experiences within the consumer journey, fueled by both human insights and data. Lilly looks forward to working with Zenith, part of Publicis Groupe, as our new media agency of record. Together, we will partner to deliver these remarkable experiences to patients and help support the future growth of the business.”